Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
1(4%)
Results Posted
8%(1 trials)
Terminated
2(8%)

Phase Distribution

Ph not_applicable
12
48%
Ph phase_1
1
4%
Ph phase_2
7
28%
Ph phase_4
4
16%

Phase Distribution

1

Early Stage

7

Mid Stage

4

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
7(29.2%)
Phase 4Post-market surveillance
4(16.7%)
N/ANon-phased studies
12(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

25

all time

Status Distribution
Active(3)
Completed(12)
Terminated(2)
Other(8)

Detailed Status

Completed12
unknown8
Terminated2
Enrolling by invitation1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.2%)
Phase 27 (29.2%)
Phase 44 (16.7%)
N/A12 (50.0%)

Trials by Status

enrolling_by_invitation14%
unknown832%
completed1248%
active_not_recruiting14%
not_yet_recruiting14%
terminated28%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT07541976Phase 2

Comparative Evaluation of Three Different Pulpotomy Agents in Primary Molars

Active Not Recruiting
NCT06795282

Post Operative Sensitivity of MTA Obturation

Completed
NCT05498337Not Applicable

Vital Pulp Therapy With Different Materials for Young Permanent Teeth

Completed
NCT06976411Phase 4

Evaluation for Healing of Iatrogenic Perforation After Repair With Different Materials

Enrolling By Invitation
NCT06889363Phase 2

Clinical and Radiographic Evaluation of Indirect Pulp Capping Using Platelet Rich Fibrin Versus Mineral Trioxide Aggregate in Deep Carious Molars: a Randomized Controlled Trial

Not Yet Recruiting
NCT02064517Phase 2

Treatments of the Necrosed Immature Teeth (REV)

Terminated
NCT06170762Not Applicable

Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Immature Permanent Teeth

Unknown
NCT06170775Not Applicable

Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth

Unknown
NCT05149651Phase 4

Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars

Completed
NCT05850780Not Applicable

Clinical and Radiographic Evaluation of Laser Photobiomodulation Pulpotomy of Primary Molars in Children

Unknown
NCT05733468Phase 4

TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars

Unknown
NCT05719987Not Applicable

Biodentine as an Apical Plug in Immature Permanent Molars

Completed
NCT05554952Not Applicable

Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries

Unknown
NCT05266859Phase 2

Efficacy of PRF and MTA as Compared to Calcium Hydroxide for Pulpotomy in Human Irreversibly Inflamed Permanent Teeth

Completed
NCT05419752Phase 2

Clinical Assessment of 3 Differant Obturation Sealers on Postoprative Pain and Swelling

Unknown
NCT04617600Not Applicable

Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.

Unknown
NCT05190783Phase 4

Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study

Completed
NCT03626740Not Applicable

Experimental Research on Deep Carious Lesion Treatment of Molars

Completed
NCT02783911Not Applicable

Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies

Terminated
NCT04018716Not Applicable

Clinical Performance of MTA Cavity Lining in the Treatment of Deep Caries Lesions

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
25